BNP Paribas Financial Markets
SGNT

BNP Paribas Financial Markets’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

BNP Paribas Financial Markets’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-7,449
Closed -$112K – 3596
2016
Q2 		$112K Buy
7,449
+3,896
+110% +$50.1K ﹤0.01% 2088
2016
Q1 		$43.2K Buy
3,553
+1,443
+68% +$20.2K ﹤0.01% 2040
2015
Q4 		$33.6K Sell
2,110
-2,650
-56% -$41.7K ﹤0.01% 2556
2015
Q3 		$73K Buy
4,760
+2,918
+158% +$63.1K ﹤0.01% 2602
2015
Q2 		$44.8K Buy
1,842
+1,316
+250% +$31.5K ﹤0.01% 2557
2015
Q1 		$12.2K Buy
+526
New +$13.9K ﹤0.01% 2628
2014
Q4 		– Sell
-1,427
Closed -$44.4K – 3885
2014
Q3 		$44.4K Buy
1,427
+1,340
+1,540% +$36.3K ﹤0.01% 2665
2014
Q2 		$2.25K Buy
+87
New +$1.93K ﹤0.01% 3038
2014
Q1 		– Sell
-244
Closed -$6.19K – 4100
2013
Q4 		$6.19K Buy
+244
New +$5.51K ﹤0.01% 2959

BNP Paribas Financial Markets's SGNT Position: Q3 2016 in Review

BNP Paribas Financial Markets sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 7,449 shares — an estimated $112K sold.

BNP Paribas Financial Markets first reported a position in SGNT in Q4 2013 and held it in 9 quarters. The position peaked at $112K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • BNP Paribas Financial Markets reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 7,449 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $112K.
  • BNP Paribas Financial Markets first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 9 quarters.
  • BNP Paribas Financial Markets's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $112K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2016, filed 5 Oct 2016.